Authors:
PAJRK E
MOL BWJ
VANLITH JMM
BLEKER OP
BILARDO CM
Citation: E. Pajrk et al., SCREENING FOR DOWNS-SYNDROME BY FETAL NUCHAL TRANSLUCENCY MEASUREMENTIN A HIGH-RISK POPULATION, Ultrasound in obstetrics & gynecology, 12(3), 1998, pp. 156-162
Authors:
PAJKRT E
VANLITH JMM
MOL BWJ
BLEKER OP
BILARDO CM
Citation: E. Pajkrt et al., SCREENING FOR DOWNS-SYNDROME BY FETAL NUCHAL TRANSLUCENCY MEASUREMENTIN A GENERAL OBSTETRIC POPULATION, Ultrasound in obstetrics & gynecology, 12(3), 1998, pp. 163-169
Authors:
PRICE KM
VANLITH JMM
SILMAN R
MANTINGH A
GRUDZINSKAS JG
Citation: Km. Price et al., FIRST-TRIMESTER MATERNAL SERUM CONCENTRATIONS OF FETAL ANTIGEN 2 IN NORMAL PREGNANCIES AND THOSE AFFECTED BY TRISOMY-21, Human reproduction (Oxford. Print), 13(6), 1998, pp. 1706-1708
Citation: Jmm. Vanlith, RECENT ADVANCES IN PRENATAL-DIAGNOSIS FOR ANEUPLOIDY - AMSTERDAM, THENETHERLANDS - MAY 1-3, 1996 - FOREWORD, Early human development, 47, 1996, pp. 1-1
Citation: Jmm. Vanlith, FIRST-TRIMESTER MATERNAL SERUM ALPHA-FETOPROTEIN AS A MARKER FOR FETAL CHROMOSOMAL DISORDERS, Prenatal diagnosis, 14(10), 1994, pp. 963-971
Citation: Jmm. Vanlith et al., FIRST-TRIMESTER MATERNAL SERUM IMMUNOREACTIVE INHIBIN IN CHROMOSOMALLY NORMAL AND ABNORMAL PREGNANCIES, Obstetrics and gynecology, 83(5), 1994, pp. 661-664
Authors:
VANLITH JMM
MANTINGH A
DEBRUIJN HWA
KLOOSTERMAN MD
KANHAI HHH
WOLF H
EVERHARDT E
CHRISTIAENS GCML
Citation: Jmm. Vanlith et al., MATERNAL SERUM CA 125 LEVELS IN PREGNANCIES WITH CHROMOSOMALLY-NORMALAND CHROMOSOMALLY-ABNORMAL FETUSES, Prenatal diagnosis, 13(12), 1993, pp. 1123-1131